Association between self-reported medication adherence and virologic outcome among human immuno-deficiency virus positive adults accessing care at a tertiary treatment centre in Rivers State, Nigeria


  • Golden Owhonda Department of Public Health and Disease Control, Rivers State Ministry of Health, Port Harcourt, Rivers State, Nigeria
  • Anwuri Luke Department of Community Medicine, College of Medical Sciences, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Rivers State, Nigeria



Association, Self-reported, Medication adherence, Virologic outcome, HIV-positive


Medication adherence reduces the risk of resistance to antiretroviral therapy. The frequently applied methods in measuring medication adherence are self-reported adherence and viral load monitoring. However, due to the backdrop of recall bias and overestimation of outcomes associated with self-reported adherence, viral load monitoring may be a better measure. This study assessed the association between medication adherence and virologic outcome among human immuno-deficiency virus (HIV) positive adults accessing care at a treatment centre in Rivers State, Nigeria. This cross-sectional study employed the systematic sampling technique to select eligible HIV-positive adults accessing care at the University of Port Harcourt Teaching Hospital between September 2022 to November 2022. Data were collected using a validated 3-item structured interviewer-administered questionnaire and analyzed with statistical package for social science (SPSS) version-26. Pearson’s Chi-square was used to test for associations at a significance level of p<0.05 and a 95% confidence interval. Confounding variables were controlled by stratifying into gender groups. 1600 participants were recruited; males (800), and females (800) with a mean age and standard deviation; males (44.53±10.50), and females (40.58±9.34). The mean self-reported optimal adherence levels were; male (98.7±6.4), and female (97.3±10.0) at p<0.001. The virologic suppression levels were; male (89.5%), and female (89.6%). The association between self-reported adherence and virologic outcome; female (90.0%, p=0.268) and male group (89.7%, p=0.485). Self-reported adherence was not associated with virologic outcomes between gender groups. Hence, viral load monitoring is recommended as a standalone method of assessing medication adherence due to its additional advantage of measuring progress toward virologic suppression.

Author Biography

Anwuri Luke, Department of Community Medicine, College of Medical Sciences, Rivers State University, Nkpolu-Oroworukwo, Port Harcourt, Rivers State, Nigeria

Community Medicine/Lecturer 1

Consultant Public Health Physician


Iacob SA, Iacob DG, Jugulete G. Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment: Clinical Points of View and Practical Considerations. Front Pharmacol. 2017;8(831):12.

Kay ES, Batey DS, Mugavero MJ. The HIV Treatment Cascade and Care Continuum: Updates, Goals, and Recommendations for the Future. AIDS Res Ther. 2016;13(35):7.

Lam WY, Fresco P. Medication Adherence Measures: An Overview. BioMed Res Int. 2015;2015(217047):12.

Orrell C, Cohen K, Leisegang R, Bangsberg DR, Wood R, Maartens G. Comparison of Six Methods to Estimate Adherence in an ART-Naïve Cohort in a Resource-Poor Setting: Which Best Predicts Virological and Resistance Outcomes? AIDS Res Ther. 2017;14(20):11.

Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-Report Measures of Medication Adherence Behavior: Recommendations on Optimal Use. Transl Behav Med. 2015;5(4):470-82.

Cunningham WE, Nance RM, Golin CE, Flynn P, Knight K, Beckwith CG, et al. Self-Reported Antiretroviral Therapy Adherence and Viral Load in Criminal Justice-Involved Populations. BMC Infect Dis. 2019;19(913): 11.

Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, et al. Improving Antiretroviral Therapy Adherence in Resource‐Limited Settings at Scale: A Discussion of Interventions and Recommendations. J Int AIDS Soc. 2017;20(1):15.

Bionghi N, Daftary A, Maharaj B, Msibi Z, Amico KR, Friedland G, et al. Pilot Evaluation of a Second-Generation Electronic Pill Box for Adherence to Bedaquiline and Antiretroviral Therapy in Drug-Resistant TB/HIV Co-Infected Patients in KwaZulu-Natal, South Africa. BMC Infect Dis. 2018;18(171):9.

Louis FJ, Buteau J, François K, Hulland E, Domerçant JW, Yang C, et al. Virologic Outcome among Patients Receiving Antiretroviral Therapy at Five Hospitals in Haiti. Plos One. 2018;13(1):12.

Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I, et al. Point‐of‐care Viral Load Monitoring: Outcomes from a Decentralized HIV Programme in Malawi. J Int AIDS Soc. 2019;22(8):9.

World Health Organization (WHO). Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. Geneva, Switzerland; 2021: 592. Available at: /publications-detail-redirect/978924003159330. Accessed on 2nd August 2022.

Henegar CE, Westreich DJ, Maskew M, Brookhart MA, Miller WC, Majuba P, et al. Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure. AIDS Behav. 2015;19(4):612-8.

Shigdel R, Klouman E, Bhandari A, Ahmed LA. Factors Associated with Adherence to Antiretroviral Therapy in HIV-Infected Patients in Kathmandu District, Nepal. HIVAIDS Auckl NZ. 2014;6:109-16.

Schaecher KL. The Importance of Treatment Adherence in HIV. Am J Manag Care. 2013;19(12):231-7.

Afe AJ, Motunrayo O, Ogungbade GO. Factors Influencing Adherence to HAART among Patients Living with HIV Infection in Southwest Nigeria: A Cross-Sectional Analysis. J HIV Retro Virus. 2017;4(1):9.

Robbins RN, Spector AY, Mellins CA, Remien RH. Optimizing ART Adherence: Update for HIV Treatment and Prevention. Curr HIV/AIDS Rep. 2014;11(4):423-33.

Viswanathan S, Justice AC, Alexander GC, Brown TT, Gandhi NR, McNicholl IR, et al. Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. JAIDS J Acquir Immune Defic Syndr. 2015;69(4):493-8.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis. Medicine (Baltimore). 2016;95(15):9.

Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and Associated Factors of Treatment Failure among HIV/AIDS Patients on HAART Attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19(37):13.

Fokam J, Billong SC, Jogue F, Ndiang SMT, Motaze ACN, Paul KN, et al. Immuno-Virological Response and Associated Factors amongst HIV-1 Vertically Infected Adolescents in Yaoundé-Cameroon. Plos One. 2017;12(11):10.

Ellman TM, Alemayehu B, Abrams EJ, Arpadi S, Howard AA, El‐Sadr WM. Selecting a Viral Load Threshold for Routine Monitoring in Resource‐Limited Settings: Optimizing Individual Health and Population Impact. J Int AIDS Soc. 2017;20(7):3.

Saberi P, Ming K, Legnitto D, Neilands T, Gandhi M, Johnson M. Novel Methods to Estimate Antiretroviral Adherence: Protocol for a Longitudinal Study. Patient Prefer Adherence. 2018;12:1033-42.

Yu Y, Luo D, Chen X, Huang Z, Wang M, Xiao S. Medication Adherence to Antiretroviral Therapy among Newly Treated People Living with HIV. BMC Public Health. 2018;18(825):8.

Hine P, Smith R, Eshun‐Wilson I, Orrell C, Cohen K, Leeflang MM, et al. Measures of Antiretroviral Adherence for Detecting Viral Non‐Suppression in People Living with HIV. Cochrane Database Syst Rev. 2018;7:18.

Chikwari CD, Ferrand RA, Simms V. Association between Self-Reported Adherence and HIV Viral Load Suppression among Older Children and Adolescents. J Acquir Immune Defic Syndr. 2017;76(3)87-9.

Maduka O, Tobin-West CI. Adherence Counselling and Reminder Text Messages Improve Uptake of Antiretroviral Therapy in a Tertiary Hospital in Nigeria. Niger J Clin Pract. 2013;16(3):302-8.

Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: A Tool for Screening Patient Adherence and Barriers to Adherence. Patient Educ Couns. 1999;37(2):113-24.

Taieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, et al. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infect Dis. 2016;3(3):7.

Ayuk A, Udonwa N, Gyuse A. Influence of Spirituality and Religion on Adherence to Highly Active Antiretroviral Therapy in Adult HIV/AIDS Patients in Calabar, Nigeria. Recent Adv Biol Med. 2017;3:48-57.

Mabunda K, Ngasama E, Babalola J, Zunza M, Nyasulu P. Determinants of Adherence to Antiretroviral Treatment among Human Immunodeficiency Virus-Infected Young Adults Attending Care at Letaba Hospital HIV Clinic, Limpopo Province, South Africa. Pan Afr Med J. 2019;32(37):14.

Puskas CM, Kaida A, Miller CL, Zhang W, Yip B, Pick N, et al. The Adherence Gap: A Longitudinal Examination of Men’s and Women’s Antiretroviral Therapy Adherence in British Columbia, 2000–2014. AIDS. 2017;31(6):827-33.

Beer L, Mattson CL, Bradley H, Skarbinski J. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States. Medicine (Baltimore). 2016;95(13):9.

Robinson AC, Knowlton AR. Gender Differences in Psychosocial Factors Associated with HIV Viral Suppression among African-American Injection Drug Users. AIDS Behav. 2016;20(2):385-94.

Oku AO, Owoaje ET, Oku OO, Monjok E. Prevalence and Determinants of Adherence to Highly Active Anti- Retroviral Therapy amongst People Living with HIV/AIDS in a Rural Setting in South-South Nigeria. Afr J Reprod Health. 2014;18(1):12(133-44).

Bonolo P, Ceccato M, Rocha G, Acurcio F, Campos L, Guimaraes M. Gender Differences in Non-Adherence among Brazilian Patients Initiating Antiretroviral Therapy. Clinics. 2013;68(5):612-20.

Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of Adherence to Antiretroviral Therapy among HIV-Positive Adults in Sub-Saharan Africa: A Systematic Review. BMJ Glob Health. 2016;1(4):13.

Eyassu MA, Mothiba TM, Mbambo-Kekana NP. Adherence to Antiretroviral Therapy among HIV and AIDS Patients at the Kwa-Thema Clinic in Gauteng Province, South Africa. Afr J Prim Health Care Fam Med. 2016;8(2):7.

Kahamba JS, Massawe FA, Nombo CI. How Gender Affects Adherence to Antiretroviral Therapy. Tanzania; 2017. Available at: https://www. publications /wp-17-196. Accessed on 30 January 2022.

Sonko I, Chung MH, Hou WH, Chen WT, Chang PC. Predictors of HIV Testing among Youth Aged 15-24 Years in the Gambia. Plos One. 2022;17(2):17.

Chineke HN, Adogu POU, Uwakwe KA, Ewuzie MU. Assessment of Level of Adherence to Antiretroviral Therapy among Human Immune Deficiency Virus/Acquired Immune Deficiency Syndrome Patients at Imo State University Teaching Hospital, Orlu, Nigeria. Niger J Gen Pract. 2015;13(1):21-5.

Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, et al. Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon. JAIDS J Acquir Immune Defic Syndr. 2015;69(3):355-64.

Federal Ministry of Health (FMOH). Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018 Technical Report. Abuja, Nigeria. 2018. Available at: › Microsites › CIHEB › documentsPDF. Accessed on 08 April 2022.

Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2021. United Nations Geneva, Switzerland. 2021. Available at: Accessed on 23 April 2022.

Conan N, Simons E, Chihana ML, Ohler L, FordKamara E, Mbatha M, et al. Increase in HIV Viral Suppression in Kwazulu-Natal, South Africa: Community-Based Cross-Sectional Surveys 2018 and 2013. What Remains to be Done? Plos One. 2022;17(3):12.

Andronescu L, Zulu PM, Jackson SS, Hachaambwa L, Claassen CW, Stafford KA. The Association between Gender and HIV Viral Suppression on Third-Line Therapy in Zambia: A Retrospective Cohort Study. Int J STD AIDS. 2019;30(5)453-9.

Ojha CR, Shakya G, Dumre SP. Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal. BioMed Res Int. 2016;6817325:7.

Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV Treatment Regimens: Systematic Literature Review and Meta-Analysis. Patient Prefer Adherence. 2019;13:475-90.

Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa B, et al. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention. Curr HIV Res. 2015;13(4):279-85.

Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. Incidences and Factors Associated with Viral Suppression or Rebound among HIV Patients on Combination Antiretroviral Therapy from Three Counties in Kenya. Int J Infect Dis. 2020;97:151-8.

Gachara G, Mavhandu LG, Rogawski ET, Manhaeve C, Bessong PO. Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa. AIDS Res Treat. 2017;e5456219:6.




How to Cite

Owhonda, G., & Luke, A. (2022). Association between self-reported medication adherence and virologic outcome among human immuno-deficiency virus positive adults accessing care at a tertiary treatment centre in Rivers State, Nigeria. International Journal Of Community Medicine And Public Health, 9(9), 3587–3594.



Review Articles